Several brokerages have updated their recommendations and price targets on shares of Exponent (NASDAQ: EXPO) in the last few weeks:
- 11/9/2026 – Exponent was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
- 11/2/2026 – Exponent was upgraded by Zacks Research from “hold” to “strong-buy”.
- 10/30/2026 – Exponent had its price target raised by UBS Group from $72.00 to $82.00. They now have a “neutral” rating on the stock.
- 10/30/2026 – Exponent had its price target raised by JPMorgan Chase & Co. from $90.00 to $100.00. They now have an “overweight” rating on the stock.
- 10/9/2026 – Exponent was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
Exponent Price Performance
EXPO stock opened at $87.31 on Monday. Exponent, Inc. has a fifty-two week low of $51.91 and a fifty-two week high of $90.51. The firm’s 50-day simple moving average is $73.30 and its 200 day simple moving average is $67.23. The stock has a market cap of $4.15 billion, a PE ratio of 37.63 and a beta of 0.66.
Exponent (NASDAQ:EXPO – Get Free Report) last announced its earnings results on Thursday, October 29th. The business services provider reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.04. Exponent had a return on equity of 34.61% and a net margin of 17.40%. The firm had revenue of $173.73 million for the quarter, compared to the consensus estimate of $149.64 million. During the same quarter in the previous year, the business earned $0.55 EPS. The firm’s revenue for the quarter was up 11.7% on a year-over-year basis. Equities analysts forecast that Exponent, Inc. will post 2.36 EPS for the current fiscal year.
Exponent Announces Dividend
Insider Activity at Exponent
In related news, VP Richard Reiss sold 1,280 shares of the firm’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $86.44, for a total value of $110,643.20. Following the completion of the transaction, the vice president owned 1,008 shares of the company’s stock, valued at approximately $87,131.52. This trade represents a 55.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is currently owned by insiders.
Exponent, Inc. is a multidisciplinary engineering and scientific consulting firm that helps clients investigate complex technical issues and manage risk. Its consultants analyze incidents such as product failures and accidents, assess potential hazards, and provide expert advice on engineering, scientific, and regulatory matters. The company’s services span fields including engineering, materials science, environmental science, health, and data analytics. Clients use Exponent’s expertise for product development and testing, litigation support, regulatory compliance, and risk assessment across a range of industries.
Featured Stories
- Five stocks we like better than Exponent
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Exponent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc and related companies with MarketBeat.com's FREE daily email newsletter.
